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Background: DNA methylation and repressive histone modifications cooperate to silence promoters. One
mechanism by which regions of methylated DNA could acquire repressive histone modifications is via methyl DNA-
binding transcription factors. The zinc finger protein ZBTB33 (also known as Kaiso) has been shown in vitro to bind
preferentially to methylated DNA and to interact with the SMRT/NCoR histone deacetylase complexes. We have
performed bioinformatic analyses of Kaiso ChIP-seq and DNA methylation datasets to test a model whereby
binding of Kaiso to methylated CpGs leads to loss of acetylated histones at target promoters.
Results: Our results suggest that, contrary to expectations, Kaiso does not bind to methylated DNA in vivo but
instead binds to highly active promoters that are marked with high levels of acetylated histones. In addition, our
studies suggest that DNA methylation and nucleosome occupancy patterns restrict access of Kaiso to potential
binding sites and influence cell type-specific binding.
Conclusions: We propose a new model for the genome-wide binding and function of Kaiso whereby Kaiso binds
to unmethylated regulatory regions and contributes to the active state of target promoters.
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Transcriptional regulationBackground
Genes are epigenetically regulated by a combination of
histone modifications and methylation of CpG dinucleo-
tides near their promoters [1,2]. Promoters that have high
levels of DNA methylation always show low activity
whereas the relationship of histone methylation and
promoter activity differs depending on exactly which
residue is methylated. For example, trimethylation of lysine
4 of histone H3 (H3K4me3) correlates with high promoter
activity whereas trimethylation of lysine 9 or lysine 27 of
histone H3 (H3K9me3 or H3K27me3) correlates with low
promoter activity. Recent studies have demonstrated
distinct spatial relationships of these two repressive histone
modifications with regions of methylated DNA [3,4]. These
analyses entailed chromatin immunoprecipitation using
antibodies that recognize specific histone modifications
followed by bisulfite sequencing of the ChIP DNA
(BisChIP-seq). One study showed that H3K27me3 can* Correspondence: pfarnham@usc.edu
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reproduction in any medium, provided the orsometimes be associated with methylated promoters but
that the H3K27me3-marked regions are repressed inde-
pendently of the level of DNA methylation [3]. A similar
study by Brinkman et al. [4] found that H3K27me3 and
DNA methylation are compatible except at CpG-rich
promoters where the two marks are mutually exclusive,
supporting a previous study by Komashko et al. [5]. The
studies of Komashko et al. also showed a very low overlap
of the sets of promoters having high levels of H3K9me3
versus high levels of DNA methylation. From their
BisChIP-seq results, Brinkman et al. suggest that H3K9me3
has a high degree of overlap with regions of methylated
DNA. However, the majority of H3K9me3 sites in the
genome are not at promoter regions and, unfortunately,
their analyses did not distinguish the DNA methylation
status of promoter versus non-promoter H3K9me3
sites. In summary, although the spatial relationship of
these repressive histone methylations has been described,
it is not yet clear if DNA methylation and H3K27me3 or
H3K9me3 cooperate to repress promoter regions.
In addition to repressive histone methylation modi-
fications, active versus inactive promoters can also beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Active promoters are marked by both acetylated
lysine 9 and acetylated lysine 27 on histone H3 (H3K9Ac
and H3K27Ac). In fact, H3K9Ac is the modified histone
most highly associated with transcriptional activity, as
shown in the integrative analysis of a large number of
datasets by the ENCODE consortium [6]. Although DNA
methylation may not cooperate with repressive histone
methylation modifications to silence genes, there may be a
functional relationship between DNA methylation and
histone deacetylases. For example, it is possible that
DNA methylation could be a signal for the binding of
a site-specific DNA-binding factor which could in
turn lead to the recruitment of a histone deacetylase. To
investigate this possible mechanism of transcriptional
repression, we have focused on ZBTB33 (also known as
Kaiso), a member of the zinc finger and BTB (ZBTB)
family of site-specific transcription factors, which has been
shown in vitro to preferentially bind a DNA motif
containing methylated CpG dinucleotides (Figure 1).
Among the ZBTB family are three proteins, ZBTB33,
ZBTB4, and ZBTB38; all of which have been shown
in vitro to use three tandem C2H2 zinc finger domains to
preferentially bind methylated DNA [7]. Specifically, Kaiso
has been shown in vitro to bind a motif containing CGCG
(Figure 1A), but only when both cytosine residues are
methylated [8]. Studies show that all three of Kaiso’s C2H2
zinc finger domains are required for its binding to this
methylated motif [8]. Other in vitro results also suggest
Kaiso is capable of binding to an unrelated unmethylatedFigure 1 Structure and function of Kaiso. (A) Kaiso is a 672 amino acid
protein-protein interactions, a nuclear localization signal, and three tandem
represent the amino acid borders of each domain. Shown below the zinc f
bind in vitro. (B) The current model for Kaiso’s activity at promoters: in the
methylated DNA, recruiting the NCoR histone deacetylation complex to th
repression of the adjacent promoter. The figure on the right shows an unm
NCoR histone deacetylation complex is not recruited to the region and sur
the promoter.motif, TCCTGCNA [9]. However, the relationship between
Kaiso binding motifs and DNA methylation has not yet
been investigated on a genome-wide scale in human cells.
A model has been proposed in which Kaiso binds to
methylated DNA in a promoter region, recruits compo-
nents of the NCoR histone deacetylase complex, and
represses transcription (Figure 1B). This model is based in
part on analysis of the MTA2 promoter. Yoon et al. [10]
showed that Kaiso can bind in vitro to a methylated version
of the sequence GGCGCGCGAGTCTTTGGGGCGCG,
which is found within the CpG island promoter of the
MTA2 gene. Using primers specific for methylated DNA,
they also showed that this sequence is methylated in HeLa
cells and they performed ChIP experiments to show that
Kaiso binds this site before, but not after, cells are treated
with 5aza-dC, a drug which reduces DNA methylation
levels. They show that Kaiso interacts with the NCoR
complex and demonstrate that Kaiso fused to the
GAL4 DNA binding domain can repress transcription
of a luciferase reporter containing a GAL4 binding
site. Finally, they show that treating cells with siRNAs
to Kaiso, 5aza-dC or the HDAC inhibitor TSA can
increase MTA2 RNA. Taken together, they proposed a
model in which Kaiso binds to the methylated MTA2
promoter and represses transcription by reducing
levels of acetylated histones near the start site. We
wished to test this model on a genome-wide scale and
therefore have analyzed Kaiso binding in normal and
cancer human cell lines, performed motif analyses of the
in vivo binding sites, and investigated the relationshipprotein, which includes an N-terminal POZ/BTB domain required for
C2H2 zinc finger domains responsible for DNA binding; numbers
inger domains are the two motifs to which Kaiso has been shown to
left figure, Kaiso’s 3 C2H2 zinc finger domains recognize and bind
e region and causing the loss of active chromatin marks and the
ethylated promoter, which is not recognized by Kaiso. As a result, the
rounding histones remain acetylated allowing for expression of
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histones, and gene expression levels. Our results suggest
that, in contrast to in vitro studies, in cells Kaiso binds to
highly active, unmethylated promoters.
Results
Identification and characterization of Kaiso-binding sites
We began by downloading the sequenced tags for all
Kaiso ChIP-seq datasets from the UCSC browser
(from the ENCODE consortium); two replicate Bowtie-
mapped ChIP-seq datasets were downloaded for GM12878,
K562, A549, HepG2, HCT116, and SK-N-SH cells. Peaks
were called for each replicate in each cell type using
Sole-Search [11,12]; see Table 1. To determine the reprodu-
cibility of the data, an overlap analysis was performed by
truncating both replicates to the same peak number and
comparing the top 40% of replicate 1 to the entire set of
peaks of replicate 2 (and vice versa, which is indicated as
the reciprocal overlap in Table 1). Of the six cell lines for
which Kaiso ChIP-seq data is available, we found that the
data from GM12878, K562, and A549 cells passed
ENCODE standards for biological replicates (number
of peaks in each set must be within a factor of two
and after truncation of peak sets to the same number,
80% of the top 40% of the peaks from one replicate must
overlap with the entire set of peaks of the other replicate);
see Landt et al. [13]. Although, the HepG2 datasets are
close to ENCODE standards (numbers of peaks are within
a factor of two and there is a 71% overlap using theTable 1 Sequencing and peak metrics for ENCODE Kaiso ChIP
GM12878 K5621
Unique reads, Rep1 16,619,899 26,444,144
Sole-Search peaks, Rep1 2,396 11,257
Median peak tag height Rep1 24 25
Unique reads, Rep2 14,307,805 19,111,076
Sole-Search peaks, Rep2 2,784 15,395
Median peak tag height, Rep2 21 21
40% overlap (reciprocal overlap) 96% (97%) 83% (92%)
Unique reads, merged Reps 30,621,961 44,860,842
Sole-Search peaks, merged Reps 12,543 18,651
Median peak tag height, merged 20 34
High-confidence peaks 1,648 3,082
Median peak tag height 34 28
IDR peaks 2,144 3,285
For each dataset, two biological replicates of Bowtie-aligned .bam files were downl
Search. The replicate with the most Sole-Search-called peaks was truncated so that
compared by ENCODE standards using the 40% overlap rule (overlap percentage sh
cell line.
1 In the K562 dataset, amplified genomic regions were discovered to contain nume
peaks were removed from the list of high-confidence K562 peaks (see Additional fil
the amplified regions were over-sequenced. As a result of removing these false pos
than the median peak tag height of the merged peak set. 2 At the time of paper su40% rule), the Kaiso ChIP-seq datasets from HCT116
and SK-N-SH cells clearly do not pass the quality
standards [13], due in large part to the great difference in
the number of peaks identified in the two replicates of
each dataset. In our studies we have focused on the Kaiso
datasets from GM12878 and K562 cells.
After determining the quality of the Kaiso ChIP-seq
datasets, the next step was to select a defined peak set for
further analysis. Because of the nature of the ChIP-seq
assay, there is not a discrete number of peaks for any
transcription factor. Rather, as more reads are acquired,
more and more peaks are identified. The peaks that are
only identified when large numbers of reads are used tend
to be much smaller than the median height of the peaks
identified when less than 10 million reads are analyzed.
The issue of small peaks is especially problematic when
two ChIP-seq replicate datasets (each of which having
more than 10 million reads) are merged. As shown in
Figure 2 for Kaiso ChIP-seq data from GM12878 cells,
there is a clear inflection point (separating a minority of
large peaks having a peak height about 40 from 90% of the
peaks having a tag height below 40) when peak height is
plotted versus ranked peak number. Although some of the
small peaks may be of biological importance, we have
found that in many ChIP-seq analyses most of the small
peaks are not reproducible. Inclusion of false-positive
(non-reproducible) small peaks can greatly skew motif
analyses and muddy insights into the relationship of a par-
ticular DNA-binding protein and transcriptional regulation.-seq datasets
A549 HepG2 HCT116 SK-N-SH
34,298,781 12,992,054 20,455,526 20,984,176
14,414 1,560 8,813 12,290
25 26 21 23
34,105,543 18,274,016 4,305,814 10,093,008
11,559 2,342 936 2,789
23 25 19 21
85% (81%) 66% (71%) 98% (94%) 65% (81%)
67,432,203 31,180,904 24,667,177 30,833,060
42,862 2,529 12,325 22,172
27 30 23 25
7,658 757 902 2,675
30 44 78 37
7,152 2,879 4,325 N/A2
oaded from the UCSC genome browser, and peaks were called using Sole-
both replicates contained the same number of peaks. Replicates were then
own). Also shown are peak metrics for high-confidence Kaiso peaks in each
rous false peaks that were not all removed by the peak-calling program; these
e 2: Figure S2). The removed peaks had very high peak tag numbers because
itive peaks, the median peak tag height of the high-confidence peaks is lower
bmission, IDR peaks had not been called for Kaiso in SK-N-SH.
Figure 2 Identification of high-confidence Kaiso peaks in GM12878 cells. The set of 12,543 Kaiso peaks identified in GM12878 cells using the
merged replicate datasets (solid line) and the set of 1,648 high-confidence Kaiso peaks (dashed line) is plotted as tag height versus ranked peak
number. The inset shows a Venn diagram of the overlap between the two Kaiso ChIP-seq replicates in GM12878 cells. The total number of peaks
in each replicate is represented in parentheses; 1,648 high-confidence peaks were found to be present in both replicates.
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Kaiso peaks in our analyses. We define high-confidence
peaks as peaks present in both replicates, regardless of peak
height. As shown in Figure 2 (inset), although 12,543 peaks
were identified in GM12878 cells using the merged
replicates, only 1,648 peaks were identified as common to
both replicates (each of which had approximately 2,400 to
2,800 peaks). The peak height versus peak rank of the
1,648 high-confidence Kaiso peaks is plotted in Figure 2A
(dashed line), for comparison with all peaks identified
using the merged datasets (solid line). Although some
small peaks with a tag height below 40 were retained
because they were reproducibly identified in both replicates,
most of the small peaks were removed using this analysis.
We next identified a set of ‘high-confidence’ Kaiso-binding
sites for each cell type using this method (Table 1); these
peaks sets were used for further analyses in our studies. We
also note that these Kaiso datasets have also been analyzed
by the ENCODE consortium using the IDR program, which
provides an estimate of the number of reproducible peaks
between two replicates [14]. Although for the three
high quality datasets (GM12878, K562, and A549),
the IDR-called peaks are similar in number to the
high-confidence peaks we have identified, we note
that there will be some difference in the exact peaks
which are retained using the different methods. Because
IDR uses the merged dataset to call a final peak set, large
peaks that are present in only one dataset may be included
whereas certain small, but reproducible, peaks may be
excluded. For the three datasets that do not pass quality
standards (HepG2, HCT116, and SK-N-SH), the IDR-called
peaks may contain many false positives; if these datasets are
used by the community, we recommend that only the
smaller set of high- confidence Sole-Search-called peaks be
used. Genomic coordinates of all high-confidence peak sets
for all Kaiso datasets can be found in Additional file 1.Testing a model of Kaiso-mediated transcriptional
repression
As described above, Kaiso has been shown to bind to
methylated DNA and has been suggested to function
as a transcriptional repressor via recruitment of
HDACs via interaction with the NCoR and SMRT
complexes [8,10,15-18]. If true, this could provide a
mechanistic explanation for a link between promoter
methylation and transcriptional repression. However,
these studies were performed in vitro and/or focused on
small sets of genes. To test this model on a genome-wide
scale, we have examined the location of Kaiso binding
sites asking the following questions: 1) Are Kaiso
binding sites located in promoter regions? 2) What is
the epigenetic status of the regulatory regions bound
by Kaiso? and 3) what is the DNA methylation status
of Kaiso binding sites?
To investigate the mechanism(s) by which Kaiso
functions on a genome-wide scale, we first determined the
location of the high-confidence Kaiso ChIP-seq peaks in
GM12878 cells relative to transcription start sites
using the Sole-Search location analysis tool. We found
that approximately 70% of high-confidence Kaiso
peaks bind within 1 kb of a transcription start site of
a Refseq gene (Figure 3A). A similar percentage of Kaiso
peaks was also found to bind within CpG islands
(Figure 3B), indicating that Kaiso prefers to bind at
GC-rich promoters. To determine if Kaiso bound to
promoters that were also bound by RNA polymerase II
(Pol2), we first identified a set of top-ranked Pol2 peaks
(Additional file 2A). To do so, we downloaded the Pol2
ChIP-seq tags from GM12878 from the ENCODE data on
the UCSC browser and called peaks using Sole-Search,
identifying approximately 50,000 peaks. Pol2 is known to
be involved in looping [19,20] and it is likely that
many of the very small peaks are due to protein-protein
Figure 3 Kaiso binds to GC-rich promoters that are also bound by Pol2. (A) Shown is the percentage of Kaiso peaks in GM12878 cells
located within 1 kilobase of a Refseq transcription start site (proximal, blue), and those located further than 1 kilobase away from a transcription
start site (distal, red). (B) Shown is the percentage of Kaiso peaks in GM12878 cells that are found within CpG islands. (C) Shown is the
percentage of Kaiso peaks in GM12878 cells that overlap the top-ranked set of Pol2 peaks (see Additional file 2).
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binding of Pol2 to transcription start sites, we chose a set
of top-ranked peaks for downstream analysis. The peaks
chosen represent the top 20% of the Pol2 peaks and the
number of tags of the lowest ranked peak chosen is 2.6-fold
over the median value of the peaks not chosen. Pol2 peaks
chosen for analysis were compared to those discarded for
their proximity to known transcription start sites. The top
Pol2 peaks are highly enriched at transcription start sites
whereas the lower background peaks are primarily
promoter distal (Additional file 2B). We then overlapped
Kaiso peaks with the selected top-ranked Pol2 peaks; the
majority of Kaiso binding sites overlap the top 20% of Pol2
peaks (Figure 3C), indicating that the promoters bound by
Kaiso are either active or poised for transcription because
they have robust Pol2 signals.
To characterize the epigenetic profiles of the Kaiso
binding sites, tag density plots were created to identify
enrichments of specific histone modifications proximal
to Kaiso binding sites. Tag density plots provide a more
accurate view of the relationship of different ChIP-seq
datasets than do simple peak overlap analyses. This is
because all tags are used in these analyses, eliminating
any user-selected cut-offs. ChIP-seq datasets for the
various histone modifications, Pol2, CTCF, and Sin3A in
GM12878 cells were downloaded from the UCSC browser
and compared to the Kaiso peak genomic coordinates.
Consistent with the overlap analysis of Kaiso peaks and
Pol2 peaks shown above, Pol2 ChIP-seq tags were highly
enriched at Kaiso peaks (Figure 4A). Analysis of the
epigenetic modifications of the nucleosomes surrounding
the Kaiso peaks revealed an enrichment of active histonemodifications at Kaiso binding sites. Specifically, there is a
large enrichment of acetylated histone H3, lysine 9: the
mark most predictive of actively-transcribed genes [6].
Another histone mark associated with open chromatin,
acetylated histone H3 lysine 27, was also highly enriched
at Kaiso peaks. These results suggesting that most Kaiso
binding sites are at active promoters were performed
using the entire set of Kaiso binding sites. However, as
shown above, 20% of the Kaiso binding sites did not
overlap with robust Pol2 peaks. It is possible that the
Kaiso bound to this subset of sites may be involved in a
different mode of transcriptional regulation. Therefore, we
separated the Kaiso peaks into those that overlapped with
Pol2 versus those that did not overlap Pol2. The Kaiso
peaks that overlapped with Pol2 had essentially the same
profile as the entire set of Kaiso peaks (Figure 4B).
However, the 378 Kaiso peaks that did not overlap with
the top-ranked Pol2 peaks had a very different epigenetic
profile; these peaks had very low enrichments for the
active histone modifications (Figure 4C). It should be
noted that the non-Pol2-bound Kaiso sites did not have a
robust enrichment for Sin3A, a component of the NCoR
HDAC complex. The highest enriched modification for this
set of peaks is H3K9me3, perhaps suggesting a link between
Kaiso binding to methylated DNA and transcriptional
repression via H3K9me3 at these sites; this subset of
Kaiso-binding is further analyzed as a separate subclass
below in the DNA methylation studies.
As a third method of characterization of the Kaiso
binding sites, we determined if Kaiso binds to promoters
having high levels of DNA methylation. Using whole
genome bisulfite sequencing (WGBS) and reduced
Figure 4 Epigenomic profiles of Kaiso binding sites in GM12878 cells. The density of ChIP-seq tags for several histone modifications and
transcription factors is plotted relative to subsets of Kaiso binding sites in GM12878; (A) all high-confidence Kaiso peaks, (B) high-confidence Kaiso
peaks that overlap with top-ranked Pol2 peaks, (C) high-confidence Kaiso peaks that do not overlap with top-ranked Pol2 peaks.
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GM12878 cells, we determined the DNA methylation
profile of the sequences surrounding the Kaiso binding
sites. As shown in Figure 5A, the set of all Kaiso peaks
and the set of Kaiso peaks that overlap Pol2 peaks both
have very low DNA methylation profiles. Thus, the
majority of the genomic regions bound by Kaiso in
GM12878 cells are GC-rich promoters that have low
levels of DNA methylation and high levels of acetylated
histones. Although Kaiso peaks not overlapping Pol2 were
found to have slightly higher methylation, this level of
methylation (approximately 30%) is similar to that found
at the center of CTCF peaks, a factor shown to bind to
unmethylated DNA [21].
If Kaiso binds to a short region of highly methylated
DNA that is not exactly in the middle of a peak having
an overall low level of DNA methylation, then it is
possible that a relationship between Kaiso binding and
DNA methylation is obscured when the analyses are
centered on the middle of the genomic regions identified
by the peak-calling program. To alleviate this concern,
the DNA methylation analyses can be centered on the
Kaiso binding motif. Kaiso has been shown to bind to a
methylated motif TCTCGCGAGA in vitro and in vivo
[18], and an unmethylated motif TCCTGCNA in vitro.
To identify an enriched motif within Kaiso binding sites,
a motif analysis was performed using Hypergeometric
Optimization of Motif EnRichment (HOMER) software
[22] to identify strings of nucleotide sequences that areenriched within Kaiso peaks. HOMER produces separate
output files for de novo identified motifs and known
motifs identified in the peak set. HOMER’s de novo
motif algorithm identified the previously published
‘methylated’ Kaiso motif TCTCGCGAGA as the most
highly represented motif in the 1,648 high-confidence
Kaiso peaks, in the 1,270 Pol2-overlapping peaks, and in
the 378 non-Pol2-overlapping peaks. 36 to 43% of the
Kaiso binding sites contained a match to this motif.
However, the previously identified ‘unmethylated’
in vitro motif TCCTGCNA was not enriched in the
Kaiso peak sets (Table 2). Absence of Kaiso binding to
the TCCTGCNA motif has also been reported by Ruzov
et al. [23], who performed ChIP-seq of a tagged Kaiso
protein; however, the significance of these results was not
clear because mouse and Xenopus Kaiso was studied in
human HEK293 cells. If Kaiso is in fact binding methylated
DNA, it is likely doing so via the Kaiso methylated motif
(because the unmethylated motif does not contain a CpG).
Therefore, we selected the subset of Kaiso peaks
containing the TCTCGCGAGA motif for further analysis
(Additional file 3). Because there is a wide distribution of
the location of this motif relative to the center of Kaiso
peaks, this could perhaps mute the observation of a
peak of DNA methylation within the actual motif. To
correct for this possibility, we centered Kaiso peaks
on the TCTCGCGAGA motif and repeated the
methylation analysis (Figure 5B). This analysis again
did not show a high enrichment of DNA methylation
Figure 5 DNA methylation analysis of Kaiso peaks. (A) The average percent DNA methylation in the sequences surrounding the Kaiso
binding sites (centered on the middle of the peak) was determined and plotted across all high-confidence Kaiso peaks (solid line), high-
confidence Kaiso peaks overlapping Pol2 (short dashed line), and high-confidence Kaiso peaks not overlapping Pol2 (long dashed line). (B) A
similar analysis was performed as in panel (A) except that only the subsets of high-confidence Kaiso peaks containing the 10 bp Kaiso motif were used
and the regions were centered on the Kaiso motif. (C) Pie charts depicting the methylation percentage of all CGCG motifs in various sets of Kaiso peaks
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the TCTCGCGAGA motif. However, these analyses use a
10 bp sliding window and therefore it is possible that the
majority of the CpG dinucleotides in the Kaiso peaks
are unmethylated (lowering the overall average DNA
methylation value of any 10 bp window) but that the
central CGCG of the recognition motif is methylated.
To determine if this is true, we identified all Kaiso
peaks having a central CGCG (Additional file 3); see
Table 2 for the percentage of peaks containing a core
CGCG. We then determined the methylation status of
each occurrence of a CpG dinucleotide in all Kaiso
peaks containing a central CGCG (Additional file 4).
Figure 5C shows the fraction of CGCG motifs in the Kaiso
peak sets that contain high (> 60%), medium (20% to 60%),
or low (< 20%) levels of methylation. Of the 4,781 CGCG








The percentage of peaks containing each motif displayed on the left side of the ch
cells. The total number of peaks in each subset is shown in parentheses.identified within high-confidence Kaiso peaks, 26 motifs
contained medium levels of DNA methylation with the
highest level being 43%. Most of the motifs containing
medium levels of methylation are found in the subset of
Kaiso peaks not overlapping Pol2.
Characterization of Kaiso binding sites in cancer cells
The analyses of Kaiso binding sites described above were
performed using GM12878 cells, which is an EBV
immortalized normal lymphoblastoid cell line. Because
Kaiso binds to promoter regions, it is possible that the
lack of correlation between Kaiso binding and DNA
methylation is simply due to the fact that most CpG
island promoters are hypomethylated in normal cells. In
contrast, in cancer cells although the majority of the
genome is hypomethylated, many promoters become







art was calculated for several subsets of Kaiso peaks in GM12878 and K562
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providing a platform for Kaiso to bind to methylated
DNA. To determine if Kaiso binds to methylated DNA in
a cancer cell, we analyzed Kaiso binding sites in the
myeloid leukemia cell line, K562. Kaiso was determined to
be similarly expressed in GM12878 and K562 by Western
blot and by RNA-seq data (see Methods). We first
identified a set of Kaiso binding sites that were
present in both replicates of the K562 Kaiso ChIP-seq
datasets. The number of these sites was much higher
than the number of GM12878 Kaiso binding sites and
therefore we performed further inspection of the
K562 peaks. We noted that a much lower percentage of
the K562 Kaiso peaks contained the Kaiso motif than did
the GM12878 peaks (12% versus 43%), suggesting that the
K562 peak set may contain a large number of false positive
peaks. K562 cells are cancer cells and have a number
of highly-amplified genomic regions. Although our
peak-calling program has features that remove many
of the false positive peaks due to genomic amplifica-
tions [11,12], we observed that a large number of
peaks from K562 cells were in the amplified regions.
We removed these amplified regions from our analyses and
the peak set was reduced to approximately 3,082 peaks,
approximately 30% of which contained a TCTCGCGAGA
motif (Additional file 5). This adjusted peak set was used
for all downstream analyses as the high-confidence Kaiso
peaks in K562. Additional file 6 contains the genomic
coordinates of the amplified regions in K562 and the Kaiso
peaks before and after removal of these amplified regions.
To determine if Kaiso binds to methylated promoters
in K562 cells, we selected the set of Kaiso peaks that
contained a CGCG motif and determined the methylation
percentage of each of the CpG dinucleotides. In this case,
we used RRBS data for DNA methylation analysis because
WGBS data is not available for K562 cells. The genomic
coverage is lower in the K562 data than in the GM12878
data; the number of CpGs with 3× coverage or greater
in the K562 RRBS dataset is 1 million, compared to
45.6 million in the GM12878 methylation data for which
we could use a combination of WGBS and RRBS.
Therefore, with a 3× coverage cut-off, we could only
analyze 1,069 CGCG motifs in the K562 Kaiso peaks.
Of these, 28 peaks contained medium levels of DNA
methylation and only two peaks contained high levels of
methylation (Figure 5C); a snapshot of the chromosomal
region containing the highest methylated CGCG motif
(63% methylated) is shown in Additional file 7.
Cell type-specific binding of Kaiso
During our analysis of the methylation status of Kaiso
binding sites, we noted that there are many more Kaiso
binding sites in K562 cells than in GM12878 cells. This
suggested that there might be cell type-specific bindingof Kaiso. To test this hypothesis, we performed an overlap
analysis of the K562 and GM12878 Kaiso high-confidence
peak sets and found that 894 peaks were shared in the
two cell types, but that 760 and 2,198 sites were uniquely
bound by Kaiso in GM12878 and K562 cells, respectively
(Figure 6A). A location analysis revealed that the common
sites were highly specific for promoter regions (Figure 6B).
In contrast, only half of the sites specific to GM12878
were at promoter regions whereas the majority of the sites
specific to K562 were located outside of promoter regions.
It is possible that Kaiso may have a different role in
transcriptional regulation when bound near versus far
from transcription start sites. Therefore, we determined
the epigenetic profiles of the promoters bound by Kaiso in
both GM12878 and K562 (mostly promoter proximal)
and of the sets of Kaiso binding sites unique to K562 cells
that were promoter proximal versus promoter distal. The
promoter proximal peaks common between K562 and
GM12878 are enriched for Pol2, the active marks H3K9Ac
and H3K27ac, and the transcription elongation mark
H3K79me2 (Figure 7A); this evidence suggests that these
regions are actively transcribed promoters. Very similar
epigenetic profiles are seen for the K562-specific Kaiso-
bound promoters (Figure 7B), suggesting that all promoters
bound by Kaiso in K562 cells (common or cell-type
specific) are actively transcribing. Interestingly, the 1,890
promoter distal peaks unique to K562 are also enriched for
Pol2 and acetylated histones (Figure 7C). The overall level
of enrichment for these active marks is lower at the distal
sites than at known promoters. This could be due either to
the presence of a small number of bona fide promoters of
genes or non-coding RNAs that are not in the Refseq
dataset or perhaps an indication of chromosomal looping
between active promoters and a distal site bound by
Kaiso. To address this issue, we overlapped the set of
K562-unique promoter distal Kaiso peaks with the top
20% of the Pol2 peaks from K562 cells. We found that 24%
of these Kaiso peaks overlap with the top-ranked Pol2
peaks, suggesting that perhaps a quarter of the 1,890 Kaiso
K562 binding sites classified as distal are at promoters that
are not annotated in Refseq dataset. Most importantly, no
subset of Kaiso peaks in K562 was determined to have an
enrichment for components of the NCoR or SMRT histone
deacetylation complexes, contrary to what would be
expected based on previously published findings [10,18].
As shown above, 46% of the Kaiso peaks in GM12878
cells and 71% of the Kaiso peaks in K562 cells are cell
type-specific. Although these sites are reproducible
(having been identified in both replicates for each cell
type) the median tag height for the cell type-specific
binding sites is lower than for the sites occupied by
Kaiso in both GM12878 and K562 cells (tag height is
shown in parentheses in Figure 8). This suggests that
Kaiso binding at the cell type-specific sites may occur
Figure 6 Characterization of cell type-specific Kaiso binding sites. (A) High-confidence Kaiso peaks in GM12878 and K562 were overlapped
to identify common peaks and cell type-specific peaks between the two datasets. (B) The common and cell type-specific Kaiso peaks were
analyzed for their position relative to the start site of transcription of the set of Refseq genes; sites within +/− 1 kb of a start site were classified as
promoter proximal whereas all other sites were classified as promoter distal.
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types. There are several mechanisms that can mediate cell
type-specific binding. One mechanism is that Kaiso could
be recruited to the genome by an interaction with cell
type-specific DNA-binding factors at sites that contain no
or weak matches to the Kaiso motif. To examine the
possibility that Kaiso is being recruited to sites inFigure 7 Epigenomic profiles of Kaiso binding sites in K562 cells. The
transcription factors is plotted relative to subsets of Kaiso binding sites in K
(B) promoter proximal peaks unique to K562, (C) promoter distal peaks uniK562 or GM12878 cells via a cell type-specific binding
partner, we first determined if the cell type-specific peaks
contained the Kaiso motif. For both GM12878 and K562
cells, we found that approximately 80 to 85% of the cell
type-specific Kaiso peaks lacked a TCTCGCGAGA motif.
To test the possibility that another site-specific factor
aided in the recruitment of Kaiso to the non-motifdensity of ChIP-seq tags for several histone modifications and
562 cells; (A) peaks common between K562 and GM12878 cells,
que to K562.
Figure 8 Motif analysis of cell type-specific Kaiso binding sites. Kaiso peaks from GM12878 and K562 were compared to identify common
and cell type-specific binding sites (the median tag height is shown in parentheses). GM12878- and K562-unique peaks were divided into two
sets of peaks, those that contain and those that lack a Kaiso motif; GM12878-unique peaks were further separated into promoter proximal and
promoter distal sets. A motif analysis was then performed for each set of peaks, identifying motifs for the GATA and CTCF families of transcription
factors in the K562-unique peaks and motifs for the ETS and Runt families of transcription factors in distal GM12878 peaks (see also Additional file 8).
Blattler et al. Epigenetics & Chromatin 2013, 6:13 Page 10 of 18
http://www.epigeneticsandchromatin.com/content/6/1/13containing cell type-specific sites, we performed a motif
analysis using HOMER. Strikingly, we found that a GATA
motif corresponded to five of the top eight most enriched
motifs in the set of K562-unique peaks that did not have a
Kaiso motif; the other 3 motifs corresponded to reported
motifs for CTCF or CTCFL (Figure 8; Additional file 8A).
We performed a similar analysis for the GM12878-specific
Kaiso peaks except that we separately analyzed promoter
proximal and distal sites not containing a Kaiso motif (this
separation was not necessary for K562 because the majority
of the sites were distal). The proximal regions did not
return significant results, likely due to the large number of
conserved sequences found at all promoter regions.
Separate analysis of the distal subset, which is more
similar to the K562 unique peaks, eliminated problems that
occur with motif analyses of promoter regions. We found
that motifs for ETS and Runt family members are enriched
in the GM12878-specific, distal, non-Kaiso motif set
(Figure 8; Additional file 8B). To determine if Kaiso
co-localizes with GATA or CTCF family members in
K562 cells or with ETS or Runt family members in
GM12878 cells, we downloaded the GATA1, GATA2,
CTCF, and CTCFL ChIP-seq data from K562 cells
and the ETS1, PU.1, and RUNX3 ChIP-seq data from
GM12878 cells from the UCSC Genome Browser and
created tag density plots relative to Kaiso peaks (Figure 9).
In K562, we found that GATA1, GATA2, CTCF, and
CTCFL were all enriched at the center of Kaiso peaks with
CTCF and GATA2 being the most enriched (Figure 9A).
Interestingly, a previous study has shown that Kaiso can
interact with CTCF [24]. When comparing binding of ETSand Runt family members to Kaiso sites in GM12878, we
again found that members of both families co-localized
with Kaiso, with RUNX3 and PU.1 having the highest
enrichment (Figure 9B).
A second mechanism that can contribute to cell type-
specific binding of a ubiquitously expressed transcription
factor is site availability. For example, high levels of DNA
methylation at a promoter results in a nucleosome-dense,
silenced region that is not accessible to transcription
factors. Thus, a promoter that has the potential to be a
Kaiso target (for example, because it contains a Kaiso
motif and is bound by Kaiso in GM12878 cells) may not
be bound by Kaiso in K562 cells if the promoter is highly
methylated and densely packed by nucleosomes. To address
whether differences in DNA methylation are responsible
for cell type-specific binding to promoters in GM12878
versus K562 cells, we determined the methylation status in
GM12878 cells of the K562-specific Kaiso peaks and the
methylation status in K562 cells of the GM12878-specific
peaks (Figure 10). We found that GM12878-unique sites
had higher overall levels of methylation in K562 cells and
K562-unique sites had higher overall levels of methylation
in GM12878, suggesting that at least a portion of the cell
type-specificity of Kaiso binding is due to exclusion from
promoters due to DNA methylation. Next, we looked at
the density of nucleosomes relative to GM12878- and
K562-unique and common binding sites. MNase-seq data
produced by ENCODE was downloaded from the
UCSC genome browser, and was used to determine the
nucleosome density of Kaiso binding sites. Tag density
plots show that sites common between GM12878 and
Figure 9 Testing bioinformatic predictions of transcription factor co-localization. The density of ChIP-seq tags for the factors identified by
motif analysis in Figure 8 were plotted relative to (A) non-motif containing K562 Kaiso peaks, and (B) promoter distal, non-motif containing
GM12878 Kaiso peaks.
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at the center of the peak (Figure 11B). Conversely,
K562-unique peaks are nucleosome-free in K562 cells,
but are occupied in GM12878 (Figure 11A). This suggests
that the occupancy of a nucleosome at a potential binding
site in GM12878 restricts the binding of Kaiso to that
region, contributing to the cell-type-specificity of Kaiso
binding. GM12878-unique sites show a slight nucleosome
occupancy increase in K562 cells, but overall, very similarFigure 10 Methylation of cell type-specific CGCG motifs in different c
GM12878-unique and K562-unique peaks was calculated using GM12878 W
showing differences in methylation between cell types.nucleosome density is observed in both cell lines at these
sites. This suggests that nucleosome occupancy plays a
lesser role in the cell type-specific Kaiso binding in
GM12878 cells (Figure 11C), perhaps due to less
overall DNA methylation at promoters in GM12878
cells. Together, the DNA methylation and nucleosome
occupancy results suggest that chromatin structure
plays a partial role in the cell type-specificity binding
of Kaiso between GM12878 and K562.ell lines. The percent methylation of individual CGCG motifs within
GBS and RRBS data and K562 RRBS data, and graphed as box plots
Figure 11 Nucleosome density of cell type-specific Kaiso peaks in GM12878 and K562. Nucleosome positioning data from MNase-seq was
used and plotted as the average density of nucleosomes relative to Kaiso peaks in A) GM12878, B) K562, and C) common sites.
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and K562 to examine the relationship between Kaiso
binding and gene expression. We identified the genes
nearest to the Kaiso binding sites that were in common
between the GM12878 and K562 Kaiso ChIP-seq
datasets and the genes that had Kaiso bound to their
promoter regions only in GM12878 or only in K562
cells. We then determined the expression levels of these
three sets of genes in both GM12878 and K562 cells
(Figure 12). We found that of these three gene sets, the
most highly expressed was the set of genes bound by
Kaiso in both GM12878 and K562 cells. Interestingly,
the GM12878-specific Kaiso targets are more highly
expressed in GM12878 cells than in K562 cells and the
K562-specific Kaiso targets are more highly expressed in
K562 cells than in GM12878 cells. Thus, we see a positive
correlation between gene expression and Kaiso binding.
Discussion
The purpose of this study was to test the previously pro-
posed model that Kaiso functions as a DNA methylation-
dependent transcriptional repressor that causes local
depletion of acetylated histones near its binding sites.
In our studies, we bioinformatically analyzed genome-wide
binding of Kaiso in normal and cancer cells, examined
the epigenetic profiles of Kaiso-bound promoters, and
determined the percentage of DNA methylation of CpGs
bound by Kaiso. Although the analyses presented in this
study focused on only two cell lines, we have also examined
the relationship between Kaiso binding sites, Pol2, and
histone modifications in HCT116, A549, and SK-N-SH
cells (see Table 1 for the number of high- confidence Kaisopeaks analyzed in each dataset). In each cell type, Kaiso is
associated with active promoters (unpublished data). In
addition, we performed whole genome bisulfite sequencing
of HCT116 and found that Kaiso binding sites are not
methylated; specifically, out of 3,051 CGCG motifs within
the high-confidence HCT116 Kaiso-binding sites, 3,036
(99.5%) had methylation levels less than 20% (unpublished
data). Thus, results from all tested cell lines are similar but
do not support the previously proposed model. Specifically,
we find that Kaiso does not bind to methylated DNA and
that it is associated with highly acetylated, actively tran-
scribed promoters. Our results are consistent with those
presented in Factorbook [25], an online repository that
hosts analyses of ENCODE transcription factor ChIP-seq
data. However, due to the large scale of that project,
individualized analyses were not performed for each factor.
For example, the Factorbook analysis of motifs found in
Kaiso binding sites included only the top 500 peaks and did
not specifically search for the non-methylated motif to
which Kaiso has been shown to bind in vitro. Another
difference is that Factorbook uses the ENCODE IDR peak
sets which, as we describe above, do not represent the same
peaks as our high confidence peaks that are found in both
ChIP-seq replicates for a given cell type. In addition, our
studies included a thorough analysis of cell type-specific
binding patterns, motifs, and nucleosome occupancy
of Kaiso sites. Finally, Factorbook did not include an
analysis of DNA methylation, which is the central
theme of our study.
Several different groups have used in vitro gel shift
assays to demonstrate that Kaiso binds to the motif
TCTCGCGAGA when both CpGs in the motif are
Figure 12 Expression of cell type-specific Kaiso-bound promoters in GM12878 and K562. RPKM values from RNA-seq experiments in
GM12878 and K562 cells were used to create box plots showing expression of cell type-specific and common Kaiso-bound genes.
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an unbiased in vitro screen for methyl DNA-binding
proteins and identified Kaiso using mass spectrometry
analysis of the proteins captured in the screen [27]. Also, a
recent study has solved the structure of Kaiso bound
to methylated DNA [28]. Clearly, Kaiso does bind to
methylated DNA in vitro. However, the vast majority
of in vivo Kaiso binding sites have very low levels of
DNA methylation. Visual inspection of the rare sites
that have high DNA methylation revealed that Kaiso
has the ability to bind methylated DNA in vivo, but
that the Kaiso peaks at those sites are among the
lowest enriched binding sites. In fact, a plot of peak
score versus percent DNA methylation clearly shows
that the strongest Kaiso sites have very low levels of
DNA methylation (Additional file 9). These data do not
support the in vitro studies that indicate that Kaiso prefers
to bind to the TCTCGCGAGA motif when both CpG
dinucleotides are fully methylated. However, we note that
we used Bowtie to align the sequenced tags to the human
genome and used Sole-Search [11,12] to call peaks. It was
possible that this combination of alignment and peak-
calling resulted in a loss of the set of highly methylated
Kaiso binding sites. To ensure that our method ofalignment and peak identification had not biased our
results, we reanalyzed the Kaiso ChIP-seq data using
LONUT, a new alignment tool which takes into account
both unique and non-unique tags (manuscript submitted)
and used BELT [29] to call peaks. Also, to eliminate the
possibility that we are missing a set of Kaiso peaks that are
highly methylated, but are not as robust or not as reprodu-
cible as the peaks called using Sole-Search, we relaxed our
stringency and called peaks on the merged Kaiso ChIP-seq
datasets for each cell type (thus not requiring that each
peak be identified in both replicates). We identified many
thousands of Kaiso binding sites in GM12878 and K562
cells, most of which were very small and found in only one
of the two replicates. We found that most of the Kaiso
binding sites identified using this method again had low
levels of DNA methylation (Additional file 10). In fact, only
12 of the 8,069 Kaiso peaks identified by LONUT in
GM12878 had greater than 50% DNA methylation. Visual
inspection of these 12 sites revealed two peaks on the X
chromosome (red arrows, Additional file 10A) within the
CpG island promoters of the PHF8 and PRDX4 genes
(the other 10 sites had low Kaiso peaks and/or were
not reproducible between the two biological replicates). A
central CGCG motif was found to be 73% methylated in
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further characterization of these promoters, they were
discovered to be expressed, and have high levels of
active histone modifications surrounding the promoter
(Additional file 10B, PHF8 shown). For both promoters, the
methylated CGCG motif identified was discovered to be
just outside the borders of the Sole-Search-called peaks and
therefore was not analyzed in Figure 5. In general,
the combination of LONUT and BELT results in the
assignment of larger genomic regions to peaks than
does the combination of Bowtie and Sole-Search; as a
result the new analysis included some new CGCG
motifs in the final dataset. However, these CGCG motifs
were not highly methylated and the ones that had modest
methylation were on the edges of the peak and unlikely to
contribute to Kaiso binding.
Binding of transcription factors in the context of
chromatin is influenced by many factors. For example,
recent ChIP-seq analyses have revealed that not all
binding sites contain the ‘expected’ motif that was derived
from in vitro binding studies [30,31]. In addition, the epi-
genetic profile of a promoter region can influence binding,
with repressive histone marks and nucleosome occupancy
limiting access of transcription factors to their binding sites
[32-34]. Taken in this context, we believe that although
Kaiso may ‘prefer’ to bind to methylated DNA, this is not
an option in the context of chromatin. Under conditions in
which the CpGs in a promoter are highly methylated, the
entire promoter region is often densely wrapped around
nucleosomes and in a repressive heterochromatic state. The
absence of a nucleosome-free region prevents access of
transcription factors to the promoter region and hence
prevents access of Kaiso to its methylated motif. Being
denied access to the preferred methylated motif, Kaiso
instead binds to the same motif in its unmethylated state. It
is interesting to note that this disconnect between in vitro
and in vivo binding to a methylated motif has been seen by
others. Bartels et al. identified RBP-J as a strong binder of
methylated DNA in vitro. However, they cannot find
evidence that this factor binds to methylated DNA in vivo
[27]. Other zinc finger proteins have been implicated in
binding methylated DNA. Quenneville et al. [35] showed
that a portion of ZFP57 consisting of two zinc fingers can
bind to a methylated TGCCGC motif in vitro and they
used bisulfite analysis of ChIP DNA to show that ZFP57
can bind to the methylated allele of three imprinted mouse
genes. However, the DNA methylation status of the other
11,000 ZFP57 ChIP-seq peaks was not analyzed and
therefore the significance of these three sites in the
context of the biological function of ZFP57 is not
clear. Spruijt et al. [36] used quantitative mass spectrometry
to identify proteins that bind to methylated DNA in vitro,
identifying the zinc finger factors KLF2, KLF4, and KLF5
as methyl DNA binding proteins. They report thatapproximately 18% of the KLF4- binding sites in mouse
ES cells show high levels of DNA methylation when using
a 100 bp window centered on the peak. However, when
the analysis is restricted to the binding motif, the DNA
methylation levels dropped significantly. Therefore, it is
not clear if KLF4 actually binds to methylated DNA in the
context of chromatin.
While we were able to identify a small number of
methylated promoters to which Kaiso binds, these genes
are enriched for active histone modifications and are
expressed. The CpG methylated sites were found to be
located away from the center of the Kaiso peak and they
do not contain the full TCTCGCGAGA motif. Therefore,
it is unclear as to whether these sites are relevant to Kaiso
binding or to promoter activity. At this point, we cannot
rule out that there are methylated TCTCGCGAGA motifs
bound by Kaiso in certain cells under certain growth
conditions. As noted above, a previous study has reported
that Kaiso binds to a methylated MTA2 promoter region
in HeLa cells [10]. Unfortunately, we do not have Kaiso
ChIP data for HeLa cells and there is no available DNA
methylation data from HeLa cells for the precise region of
the MTA2 promoter that corresponds to the reported
Kaiso binding site. However, in HeLa cells the MTA2
promoter has marks of open chromatin and is bound by
Pol2; furthermore, the MTA2 transcript is expressed in
HeLa cells (Additional file 11). Therefore, if Kaiso does
bind at the MTA2 promoter in HeLa cells, it does not
silence transcription. We have examined the relationship
of Kaiso binding and MTA2 expression in six other cell
types. We find that Kaiso binds to the MTA2 promoter in
K562, A459, and SK-N-SH cells, and in all of these cell
lines the MTA2 promoter has acetylated histones.
Another study [15] suggested that Kaiso binds to and
represses the CDKN2A, HIC1, and MGMT promoters
in a methylation-dependent manner in HCT116 cells.
However, ChIP-seq data indicates that in HCT116
cells Kaiso does not bind within the genomic regions
of these promoters. A recent study [37] claims that
Kaiso binds the cyclin D1 CpG island promoter via a ‘KBS
motif ’, TCCTGCNA, 69 bp upstream of the transcription
start site and functions to repress expression of the cyclin
D1 gene in HCT116 and MCF7 cells. They show that the
methylation of three adjacent CpG dinucleotides helps to
stabilize Kaiso’s interaction with sequences containing the
cyclin D1 promoter using in vitro assays, and that Kaiso
binds the region by ChIP. However, ENCODE ChIP-seq
data from HCT116 shows that Kaiso is not enriched at
the cyclin D1 promoter and RRBS data shows that the
region encompassing the KBS motif 69 bp upstream of the
transcription start site is unmethylated in both HCT116
and MCF7. The gene is also bound by Pol2 and acetylated
histones, and is expressed in both cell lines. Thus, it is hard
to find a clear relationship between Kaiso binding and
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son of the expression levels of the genes bound by Kaiso in
both GM12878 and K562 versus the expression of the
genes whose promoters are bound by Kaiso in a cell
type-specific manner, we find a positive correlation
between Kaiso- binding and gene expression (Figure 12).
Although many promoters are bound by Kaiso in
multiple cell types, we did observe cell type-specific
binding. While we do not yet fully understand what
specifies cell type-specific binding of Kaiso, it appears
that in some cases increased DNA methylation and
compact chromatin structure may prevent Kaiso from
binding in a particular cell type. Our studies also suggest
that interaction with other transcription factors can
influence cell type-specific binding of Kaiso. Motif
analysis indicated that most cell type-specific Kaiso
binding sites did not contain the TCTCGCGAGA
motif, suggesting that Kaiso may be recruited to these
sites in a manner distinct from direct binding to its
motif. To test this hypothesis we performed a motif
analysis and found motifs for GATA and CTCF family
members in the K562-specific Kaiso peaks and for ETS and
Runt family members in the GM12878-specific Kaiso
peaks. These results suggested that Kaiso might co-localize
with these specific factors in GM12878 or K562 cells.
ChIP-seq data from the ENCODE project confirmed the
validity of these bioinformatic predictions; we found CTCF,
GATA1, and GATA2 to be highly-enriched at K562-unique
Kaiso binding sites, and RUNX3 and PU.1 to be highly
enriched at GM12878-unique Kaiso binding sites. We note
that a previous study has shown that Kaiso can interact
with CTCF [24]. Taken together with our genome-wide
analyses, we suggest that CTCF may help to recruit
Kaiso to certain locations in the genome. Physical
interaction studies of Kaiso and GATA factors have
not been performed; therefore, further work is necessary to
determine the significance of these co-localizations. We
note that a previous study suggested that Kaiso can interact
with ZNF131 [16]. However, the ZNF131 motif was not
identified in any of our unbiased motif analyses. We
performed a direct search for the ZNF131 motif allowing
up to two mismatches, and found that only 24 of 603
GM-specific peaks that lack a Kaiso motif and only
38 of 1855 K56-specific peaks that lack a Kaiso motif
contained a match to the ZNF131 motif. There is no
ChIP-seq data for ZNF131, but based on motif analyses, it
may not play an important role in recruiting Kaiso to the
genome. Our results also indicate that nucleosome
occupancy plays a role in dictating Kaiso’s cell type-
specific binding between GM12878 and K562 (Figure 11).
Specifically, binding sites unique to K562 cells show
reduced nucleosome occupancy relative to the same
genomic loci in GM12878 cells. However, in GM12878
cells, it appears that the positioning of nucleosomes playsa lesser role in differential Kaiso binding between the two
cell types.
Conclusions
In summary, and in contrast to prediction, all of our
analyses suggest that there is a strong positive relationship
between the binding of Kaiso, the absence of DNA
methylation, the presence of active marks on a promoter,
and RNA expression levels. Thus, Kaiso does not appear to
play a major role in creating a repressive promoter
structure. Rather, our studies suggest that instead of
recruiting repressive proteins such as HDACs, Kaiso
may recruit positively-acting transcription factors. Future
studies are needed to more precisely define the mechanism
by which Kaiso contributes to the overall expression level
of its target genes. Importantly, our findings establish a
clear disconnect between in vitro studies and in vivo
studies. Rather than DNA methylation of a small motif, the
chromatin landscape, along with the cooperation of Kaiso
with other factors, dictates Kaiso binding patterns. We
suggest that the fact that Kaiso may prefer a methylated
motif is not relevant to in vivo function because the
methylated Kaiso motifs are not accessible for binding. A
recent study has highlighted the fact that two-thirds of the
members of the large family of KRAB domain-containing
zinc finger proteins contain a specific argenine-histidine
linker sequence between the C2H2 zinc finger domains
that may allow recognition of methylated cytosines [38].
Future studies may successfully identify a transcription
factor that can bind to a methylated motif in the context
of chromatin and contribute to gene silencing.
Methods
ChIP-seq peak calling and analysis
Two replicate Bowtie-mapped ChIP-seq datasets were
downloaded for GM12878, K562, A549, HepG2, HCT116,
and SK-N-SH from the UCSC browser. All Kaiso ChIP-seq
experiments were carried out in the Myers Lab using Santa
Cruz Biotechnology antibody sc-23871. The antibody
has been validated to be specific to Kaiso as required
by ENCODE standards [13], using Western blot analysis
and mass spectrometry. We note that the antibody
validation document shows that the levels of Kaiso in
GM12878 and K562 are similar. The Kaiso (ZBTB33)
antibody validation document from the ENCODE
consortium can be found at http://genome-preview.ucsc.
edu/cgi-bin/hgEncodeVocab?term=%22ZBTB33%22. Peaks
were called for each replicate in each cell type using
Sole-Search [11,12]. The parameters used in the Sole-
Search program for all Kaiso datasets were as follows:
a permutation of 5, fragment length of 150, alpha
value of 0.0010, an FDR of 0.0010, and a peak merge dis-
tance of 0. To determine the reproducibility between the
two replicates for the Kaiso datasets (and to compare
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files for each replicate were compared using the overlap
analysis tool in Sole-Search [11,12]. A file containing the
genomic locations of all CpG islands were downloaded
from the UCSC genome browser. To determine the
location of Kaiso peaks (and the location of the Pol2
top-ranked peaks versus the Pol2 peaks excluded
from analysis) relative to transcription start sites, the
location analysis tool of Sole-Search was used. The
epigenetic profiles of the Kaiso binding sites were
analyzed using tag density plots that were created
using Hypergeometric Optimization of Motif EnRichment
software (HOMER, http://biowhat.ucsd.edu/homer/index.
html) [22]. All histone modification and transcription
factor ChIP-seq datasets used in comparison to Kaiso
peaks were downloaded from the UCSC genome browser.
DNA methylation analysis
To determine the DNA methylation status of the genomic
regions corresponding to Kaiso peaks, a BigBed file for
GM12878 WGBS data was downloaded from the UCSC
genome browser and was converted to BED format using
the BigBedtoBed script available at http://hgdownload.soe.
ucsc.edu/admin/exe/macOSX.i386/. HOMER [22] was then
used to plot the percent methylation across Kaiso peak
regions using the annotatePeaks.pl script and the ‘-ratio’
option, comparing peak files to tag directories created using
the ‘-mCpGbed’ option. The resulting output files were
used to create histograms plotting the average percent
methylation in 500bp regions surrounding the center of
Kaiso peaks using a bin size of 10bp. To identify an
enriched motif within Kaiso-binding sites, a motif analysis
was performed using HOMER to identify strings of nucleo-
tide sequences that are enriched within Kaiso peaks. The
findMotifsGenome.pl command was run in HOMER using
hg19 as the reference genome. To limit the motif analysis
to regions pulled down by ChIP, the analysis was limited to
sequences contained within each peak using the ‘-size given’
option. For some analyses, we centered Kaiso peaks on the
methylated motif using the annotatePeaks.pl script and the
-center option in HOMER. To determine the methylation
status of individual CGCG motifs contained with peaks, the
genomic coordinates of each motif was compared to WGBS
and/or RRBS data, and a beta value was assigned to each
CpG within the motif. For GM12878 methylation analyses,
WGBS and RRBS data was combined to achieve higher
genomic coverage; for K562 analyses, only RRBS data was
available. Only bases with a minimum 3× sequencing
coverage were used in methylation analyses.
RNA-seq analysis
The RefSeq gene annotation files for RNA-seq data in
GM12878 and K562 were downloaded from the
UCSC genome browser (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeCaltechRnaSeq/).
A union file was created by combining all transcripts for
individual genes with multiple transcripts. For both cell
types, all replicates were combined for analysis. All reads
were aligned to the hg19 reference genome using the
bowtie aligner, and those uniquely mapped were used to
calculate the expression level as reads per kilobase per
million reads (RPKM), using the following formula:
RPKM ¼ n=NL 1:0 108
where n is the number of mapped reads localized within
exons, N is the total number of uniquely mapped
reads in the experiment, and L is the length of gene
body summing from all union exons in base pairs.
We note that Kaiso had an RPKM value of
0.004081966 in GM12878 and 0.004755255 in K562,
and ranked within the top 40% of expressed genes in
both cell types. To verify the difference among groups
of peaks (K562-unique, common, GM12878-unique),
the Mann-Whitney rank test was applied.
Additional files
Additional file 1: Chromosomal locations and peak scores for Kaiso
peaks sets in all cell lines.
Additional file 2: Peak selection for Pol2 in GM12878 cells. Shown
are the peaks called using Sole-Search for the merged replicate
datasets of Pol2 in GM12878 (panel A). The parameters used in the
Sole-Search peak calling were as follows: permutation of 5, fragment
length of 150, alpha value of 0.0010, an FDR of 0.0010, and a peak merge
distance of 0. The top 20% of the called peaks were used (tag height >
50). The arrow indicates the position at which the peak list was
truncated. Panel B shows the location analysis for Pol2 peaks that were
used in our analysis (red) and those that were discarded (blue).
Additional file 3: HOMER Annotation of Kaiso peak files in
GM12878 and K562, including locations of Kaiso motifs.
Additional file 4: Chromosomal location and percent methylation
of CGCG motifs within GM12878 and K562 Kaiso peaks.
Additional file 5: Motif analysis of subsets of K562 Kaiso peaks
identified in highly amplified genomic regions. As shown, the Kaiso
motif is not highly represented in the removed peaks. The adjusted high-
confidence peak set is used for analyses in this paper. However, the
genomic coordinates of the retained and removed peaks are provided in
Additional file 6.
Additional file 6: Peak files used in the removal of amplified
regions in K562 cells.
Additional file 7: Methylation of Kaiso peaks in K562. Snapshot of
the region on chromosome 6 containing the highest methylated
CGCG motif identified within Kaiso K562 high-confidence peaks. The
ChIP-seq track for Kaiso is shown in black, with called peaks represented
by black bars below the track. ChIP-seq tracks for Pol2 and histone
modifications are shown in blue. The inset shows a zoom in of the
region bound by Kaiso containing a methylated CGCG motif. Red bars in
the RRBS track represent methylated cytosines.
Additional file 8: Motif analysis of cell type-specific peaks lacking a
Kaiso motif. (A) K562 Kaiso peaks that lack a Kaiso motif were searched
for known motifs for other TFs using Homer. (B) GM12878-unique distal
Kaiso peaks that lack a Kaiso motif were searched for known motifs for
other TFs using Homer.
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http://www.epigeneticsandchromatin.com/content/6/1/13Additional file 9: Plot of DNA methylation versus peak rank. The
methylation status of each CGCG motif within Kaiso peaks was calculated
using WGBS and RRBS data (for GM12878, left panel) and RRBS (for K562,
right panel), and plotted relative to the score of the peak containing the
motif. The left panel shows high-confidence Kaiso peaks in GM12878 and
the right panel shows high- confidence Kaiso peaks in K562.
Additional file 10: Methylation of Kaiso peaks identified by LONUT.
(A) Comparison of methylation levels within peaks called by different
programs. Peaks were called by BELT using non-uniquely mapped tags
(left) and uniquely-mapped tags (middle) that were mapped using
LONUT. These peaks were compared to Sole-Search-called peaks (right)
for methylation of CGCG motifs. Red arrows indicate CGCG motifs
identified in the promoters of the PHF8 and PRDX4 genes. (B) Genome
browser snapshot of the region surrounding the PHF8 gene, where a
CGCG motif is 73% methylated in GM12878 cells. ChIP-seq tracks for Pol2
and histone modifications are shown in red and the Kaiso ChIP-seq track
is shown in black.
Additional file 11: MTA2 promoter showing no DNA methylation
and active promoter marks in HeLa cells. Genome browser snapshot
showing the MTA2 gene. The region analyzed for Kaiso-binding and DNA
methylation in Yoon et al. is represented by the black box under the red
arrow. RRBS tracks for several cell types are shown in green, red, and
yellow, but is absent in all cell lines for the region in question. ChIP-seq
density tracks for Pol2 and histone modifications in HeLa cells are shown
in grey-scale.
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